Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Advertising

Press Release

Active Biotech AB - Interim report January - September 2017

Active Biotech
Posted on: 09 Nov 17

    

Third quarter in brief

  • The company's application related to one of the patent families in the SILC project was granted patent in the US
  • Preclinical data for a SILC substance was published in the scientific journal Cancer Immunology Research
  • The process to divest the company's research facility at Ideon in Lund has been initiated, for further comments related to the company's liquidity situation see the section "Outlook, including significant risks and uncertainties"

Events after the end of the period

  • In October, Active Biotech's partner Teva Pharmaceutical Industries Ltd presented new data concerning laquinimod for the treatment of multiple sclerosis at the ECTRIMS-ACTRIMS congress
  • The Board of directors has decided to initiate negotiations with the trade unions related to the winding up of the companies animal test facility

Financial summary

SEK M July-Sept. Jan.-Sept. Full-year
  20172016201720162016
      
Net sales5.14.114.812.019.0
Operating loss-6.5-11.1-44.2-41.6-55.1
Loss for the period-8.4-12.4-48.6-44.8-59.6
Loss per share, before and after dilution (SEK)-0.09-0.14-0.50-0.50-0.65
Cash and cash equivalents (at the end of the period)  35.639.977.7

For further information, please contact:

  Helén Tuvesson, CEO
  Tel: +46 (0)46-19 21 56

 

  Hans Kolam, CFO
  Tel: +46 (0)46 19 20 44

 
Active Biotech AB
(Corp. Reg. No. 556223-9227)
Box 724, SE-220 07 Lund
Tel: +46 (0)46-19 20 00

 

The report is also available at www.activebiotech.com .

Active Biotech AB - Interim report January - September 2017


This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients.

The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.

Source: Active Biotech via GlobeNewswire
HUG#2148297
GlobeNewswire
globenewswire.com

Last updated on: 10/11/2017

Advertising
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.